Scout | Synthetic IgM Antibody Controls for Measles, Mumps, and Rubella Assays

This opportunity is no longer accepting applications.

grant

Synthetic IgM Antibody Controls for Measles, Mumps, and Rubella Assays

This grant opportunity seeks Phase I SBIR proposals (but not Fast-track or Phase I clinical trials) to address the public health challenges posed by measles, rubella, and mumps infections. There is funding for one anticipated award. For Phase I, the budget is up to $243,500 for a duration of up to 6 months. If successful, Phase II could provide further funding up to $2,045,816 for up to two ad…

Source

Agency: Centers for Disease Control and Prevention

Program: SBIR

Dates

Opportunity Released: August 2, 2024

Open for Submission: August 2, 2024

Application Window Closes: October 18, 2024

Keywords

measles

mumps

rubella

IgM antibodies

synthetic antibody controls

diagnostic assays

public health

acute infections

Phase I SBIR

viral infections

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers